Literature DB >> 25762499

Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjögren's syndrome.

Tamara Peric1, Dejan Markovic2, Bojan Petrovic3, Vesna Radojevic4, Tatjana Todorovic5, Biljana Andjelski Radicevic5, Radmila Jancic Heinemann4, Gordana Susic6, Aleksandra Peric Popadic7,8, Vesna Tomic Spiric7,8.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate efficacy of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and casein phosphopeptide-amorphous calcium fluoride phosphate (CPP-ACFP) containing pastes among individuals with Sjögren's syndrome (SS).
MATERIALS AND METHODS: Thirty patients were randomised into three groups: CPP-ACP, CPP-ACFP, and 0.05 % NaF to be used two times a day during a 28-day experimental period. Saliva was analysed for flow rate, pH, buffering capacity and mineral concentrations. Dental plaque was examined for pH. Following the formation of artificial carious lesion, participants wore enamel slabs for an in situ remineralisation study. Remineralisation potential was examined using scanning electron microscope (SEM) and energy dispersive spectroscopic (EDS) technique. SE microphotographs were subsequently analysed for area, diameter, perimeter, roundness and the number of enamel defects and percentage of tooth surface affected by defects.
RESULTS: At the end of the experimental period, a slight increase of salivary pH could have been observed. No differences in mineral composition of saliva were noted. The use of CPP-ACP and CPP-ACFP contributed to a significant rise of plaque pH. Image analysis revealed excessive reduction of defects' dimensions in the three experimental groups, and a decrease of the number of enamel defects in the CPP-ACP and CPP-ACFP groups. The EDS analysis did not show differences in Ca/P, Ca/O and P/O ratios in any of the treatment groups.
CONCLUSION: CPP-ACP and CPP-ACFP hold promise as remineralising agents for patients with SS. CLINICAL RELEVANCE: Pastes containing CPP-ACP/CPP-ACFP show enhanced remineralisation potential compared with NaF mouthrinse in patients with SS.

Entities:  

Keywords:  Casein phosphopeptide-amorphous calcium fluoride phosphate; Casein phosphopeptide-amorphous calcium phosphate; Dental plaque; Enamel remineralisation; Saliva; Sjögren’s syndrome

Mesh:

Substances:

Year:  2015        PMID: 25762499     DOI: 10.1007/s00784-015-1444-1

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  59 in total

1.  Remineralization of enamel subsurface lesions by sugar-free chewing gum containing casein phosphopeptide-amorphous calcium phosphate.

Authors:  P Shen; F Cai; A Nowicki; J Vincent; E C Reynolds
Journal:  J Dent Res       Date:  2001-12       Impact factor: 6.116

Review 2.  Xerostomia: etiology, recognition and treatment.

Authors:  James Guggenheimer; Paul A Moore
Journal:  J Am Dent Assoc       Date:  2003-01       Impact factor: 3.634

3.  Enamel subsurface lesion remineralisation with casein phosphopeptide stabilised solutions of calcium, phosphate and fluoride.

Authors:  N J Cochrane; S Saranathan; F Cai; K J Cross; E C Reynolds
Journal:  Caries Res       Date:  2008-01-15       Impact factor: 4.056

4.  The effect of casein and calcium containing paste on plaque pH following a subsequent carbohydrate challenge.

Authors:  Paul Chetcuti Caruana; Sami Al Mulaify; Rebecca Moazzez; David Bartlett
Journal:  J Dent       Date:  2009-04-29       Impact factor: 4.379

5.  Comparative analysis of three commercial saliva testing kits with a standard saliva buffering test.

Authors:  Y Kitasako; M F Burrow; M Stacey; L Huq; E C Reynolds; J Tagami
Journal:  Aust Dent J       Date:  2008-06       Impact factor: 2.291

6.  Consumption of milk with added casein phosphopeptide-amorphous calcium phosphate remineralizes enamel subsurface lesions in situ.

Authors:  G D Walker; F Cai; P Shen; D L Bailey; Y Yuan; N J Cochrane; C Reynolds; E C Reynolds
Journal:  Aust Dent J       Date:  2009-09       Impact factor: 2.291

7.  Prevention of xerostomia-related dental caries in irradiated cancer patients.

Authors:  S Dreizen; L R Brown; T E Daly; J B Drane
Journal:  J Dent Res       Date:  1977-02       Impact factor: 6.116

8.  Critical pH in resting and stimulated whole saliva in groups of children and adults.

Authors:  P Anderson; M P Hector; M A Rampersad
Journal:  Int J Paediatr Dent       Date:  2001-07       Impact factor: 3.455

Review 9.  Review: The physiology of saliva and transfer of drugs into saliva.

Authors:  Johan K M Aps; Luc C Martens
Journal:  Forensic Sci Int       Date:  2005-06-10       Impact factor: 2.395

10.  Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs.

Authors:  Jacqueline M Plemons; Ibtisam Al-Hashimi; Cindy L Marek
Journal:  J Am Dent Assoc       Date:  2014-08       Impact factor: 3.634

View more
  1 in total

1.  Casein Phosphopeptide-Amorphous Calcium Phosphate Reduces Streptococcus mutans Biofilm Development on Glass Ionomer Cement and Disrupts Established Biofilms.

Authors:  Stuart G Dashper; Deanne V Catmull; Sze-Wei Liu; Helen Myroforidis; Ilya Zalizniak; Joseph E A Palamara; N Laila Huq; Eric C Reynolds
Journal:  PLoS One       Date:  2016-09-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.